Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Recruiting · NCT07725380 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 1 / Phase 2 | 2026-09-03 | NCT07725380 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 162 |
| Healx USA, Inc | 1 |
| National Pediatric Cancer Foundation | 7 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Moffitt Cancer Center | Tampa | United States | 523 |
| Montefiore Medical Center | The Bronx | United States | 198 |
| Nationwide Children's Hospital | Columbus | United States | 309 |
| Washington University in St. Louis | St Louis | United States | 79 |